These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
622 related items for PubMed ID: 15193467
1. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, Heward CB, Hecht H, Jaff MR, Harman SM, Women's Health Initiative. Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467 [Abstract] [Full Text] [Related]
2. What can we learn from design faults in the Women's Health Initiative randomized clinical trial? Tan O, Harman SM, Naftolin F. Bull NYU Hosp Jt Dis; 2009 Jun; 67(2):226-9. PubMed ID: 19583558 [Abstract] [Full Text] [Related]
3. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? Rosano GM, Vitale C, Fini M. Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159 [Abstract] [Full Text] [Related]
4. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM, Naftolin F, Brinton EA, Judelson DR. Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [Abstract] [Full Text] [Related]
5. Hormone therapy in the WHI era. Burger HG. Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027 [Abstract] [Full Text] [Related]
6. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators. Am J Epidemiol; 2006 Apr 01; 163(7):589-99. PubMed ID: 16484450 [Abstract] [Full Text] [Related]
7. WHI and aftermath: looking beyond the figures. Pines A. Maturitas; 2005 May 16; 51(1):48-50. PubMed ID: 15883109 [Abstract] [Full Text] [Related]
13. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative. Rigby AJ, Ma J, Stafford RS. Menopause; 2007 Oct 16; 14(5):853-8. PubMed ID: 17429334 [Abstract] [Full Text] [Related]
14. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators. Am J Epidemiol; 2005 Sep 01; 162(5):404-14. PubMed ID: 16033876 [Abstract] [Full Text] [Related]
15. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G. J Cardiovasc Med (Hagerstown); 2009 Jan 01; 10(1):85-92. PubMed ID: 19145119 [Abstract] [Full Text] [Related]
16. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J. Maturitas; 2005 Sep 16; 52(1):11-7. PubMed ID: 16023804 [Abstract] [Full Text] [Related]
17. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause. Langer RD. Climacteric; 2010 Aug 16; 13(4):303-6. PubMed ID: 20540591 [Abstract] [Full Text] [Related]